From Alzheimer's to Cancer: The Expanding Role of Neurodegenerative Disease Drugs and GSK-3β Inhibitors
The spectrum of diseases potentially treatable with GSK-3β inhibitors has expanded dramatically, encompassing everything from Alzheimer's disease and other neurodegenerative disorders to diabetes, cancer, and cardiovascular diseases. Neurodegenerative disease drugs have evolved to meet the diverse needs of patients, with GSK-3β inhibitors offering promising therapeutic approaches...
0 Комментарии 0 Поделились 9 Просмотры 0 предпросмотр